StocksFin Logo
Abbott Laboratories country of incorporation
|
|
Mr. Robert Ford
|
113,000 employees
NYSE | Healthcare | Medical Devices
CVS Health Corporation country of incorporation
|
|
Mr. Larry Merlo
|
216,000 employees
NYSE | Healthcare | Healthcare Plans
Q322 reported Nov 1, 2022 Reporting Period
$10.41B -4.7% vs. Q321 Revenues Q322
55.53% -6.7% vs. Q321 Gross Profit Margin
13.78% -28.3% vs. Q321 Net Profit Margin
2.31B -14.4% vs. Q321 Free Cash Flow Q322
$1.15 -3.2% vs. Q321 EPS Q322
Period
Profitable?
Revenue Growth?
Net Profit Growth?
FCF Growth?
OCF Growth?
EPS Growth?
Pays Dividend?
Q322
0.68%
Q322
2.55%
Q322 reported Nov 2, 2022 Reporting Period
$81.16B 10% vs. Q321 Revenues Q322
16.48% -4.3% vs. Q321 Gross Profit Margin
-4.21% ! -294.4% vs. Q321 Net Profit Margin
8.54B 54.7% vs. Q321 Free Cash Flow Q322
$-2.6 ! -314.9% vs. Q321 EPS Q322
-
Period
Profitable?
Revenue Growth?
Net Profit Growth?
FCF Growth?
OCF Growth?
EPS Growth?
Pays Dividend?
Q322
0.68%
Q322
2.55%
Loading...
Loading...
Loading...
Loading...
Ratios
As of
Sep 30, 2022
Dec 31, 2022
Quick Ratio
1.22
0.62
Current Ratio
1.86
0.94
Cash Ratio
0.72
0.19
Price to Book
3.38
1.61
Price to Sales
11.6
0.35
Price to Earnings
21.03
27.53